Oncology Institute, Inc. 8-K

What Happened

On May 7, 2026, Oncology Institute, Inc. (TOI) filed a Form 8-K (Item 2.02) to furnish a press release announcing its results of operations and financial condition for the three months ended March 31, 2026. The press release was included as Exhibit 99.1 to the filing and the cover page interactive data file was provided in Inline XBRL (Exhibit 104).

Key Details

• Filing date: May 7, 2026 (Form 8-K, Item 2.02).
• Period covered: Quarterly results for the three months ended March 31, 2026.
• Press release furnished as Exhibit 99.1; Inline XBRL cover page included as Exhibit 104.
• The filing notifies investors that the company has publicly disclosed its quarterly financial results (see Exhibit 99.1 for full figures and commentary).

Why It Matters

This 8-K signals that TOI has released its quarterly earnings information; investors should review the furnished press release (Exhibit 99.1) and any related financial statements for revenue, net income/loss, cash position, and management commentary. Those details are material to assessing near-term performance and planning investment decisions; because the press release is furnished (not filed), investors should also watch for any subsequent filings that may provide additional financial statements or formal disclosures.